share_log

新銳醫藥:致非登記股東之通知信函及申請表格

NEW RAY MEDIC: Notification Letter and Request Form to Non-Registered Shareholders

HKEX ·  Sep 17, 2024 20:35

Summary by Moomoo AI

新銳醫藥國際控股有限公司於2024年9月19日向非登記股東發出通知,公告其2024年中期報告已可在公司及香港聯合交易所有限公司網站上獲得。公司鼓勵股東透過網站閱讀報告,並提供選項讓股東如有困難可索取印刷版報告。公司將透過電郵或郵寄方式通知股東,前提是股東透過銀行、經紀、託管人等中介機構提供有效的聯絡方式。若股東未提供聯絡方式,則不會收到通知。股東可於工作時間內聯絡股份過戶登記分處查詢。
新銳醫藥國際控股有限公司於2024年9月19日向非登記股東發出通知,公告其2024年中期報告已可在公司及香港聯合交易所有限公司網站上獲得。公司鼓勵股東透過網站閱讀報告,並提供選項讓股東如有困難可索取印刷版報告。公司將透過電郵或郵寄方式通知股東,前提是股東透過銀行、經紀、託管人等中介機構提供有效的聯絡方式。若股東未提供聯絡方式,則不會收到通知。股東可於工作時間內聯絡股份過戶登記分處查詢。
On September 19, 2024, New Ray Medic International Holdings Limited issued a notice to non-registered shareholders, announcing that its mid-year report for 2024 can now be accessed on the company's website and the Hong Kong Stock Exchange's website. The company encourages shareholders to read the report online and offers options for shareholders who have difficulties to obtain a printed version of the report. The company will notify shareholders through email or postal mail, provided that shareholders have provided valid contact information through banks, brokers, custodians, or other intermediaries. Shareholders who do not provide contact information will not receive the notification. Shareholders can contact the share transfer registration office during working hours for inquiries.
On September 19, 2024, New Ray Medic International Holdings Limited issued a notice to non-registered shareholders, announcing that its mid-year report for 2024 can now be accessed on the company's website and the Hong Kong Stock Exchange's website. The company encourages shareholders to read the report online and offers options for shareholders who have difficulties to obtain a printed version of the report. The company will notify shareholders through email or postal mail, provided that shareholders have provided valid contact information through banks, brokers, custodians, or other intermediaries. Shareholders who do not provide contact information will not receive the notification. Shareholders can contact the share transfer registration office during working hours for inquiries.
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more